Baby powder (Powder) Instructions for Use
ATC Code
D08A (Antiseptics and disinfectants)
Active Substance
Zinc oxide (Ph.Eur. European Pharmacopoeia)
Clinical-Pharmacological Group
Drug with astringent and drying action for external use
Pharmacotherapeutic Group
Preparations with emollient and protective action. Zinc preparations
Pharmacological Action
Zinc oxide exerts a drying, adsorbent, astringent, and disinfectant action. It reduces exudation and weeping, which alleviates local manifestations of inflammation and irritation.
Indications
Diaper rash, intertrigo, miliaria, dermatitis, ulcerative skin lesions, superficial wounds and burns.
ICD codes
| ICD-10 code | Indication |
| L20.8 | Other atopic dermatitis (neurodermatitis, eczema) |
| L22 | Diaper dermatitis |
| L23 | Allergic contact dermatitis |
| L24 | Irritant contact dermatitis |
| L25 | Unspecified contact dermatitis |
| L30.0 | Nummular eczema |
| L30.4 | Erythematous intertrigo |
| L30.9 | Dermatitis, unspecified |
| L74.3 | Unspecified miliaria |
| L89 | Decubitus ulcer and pressure area |
| L98.4 | Chronic skin ulcer, not elsewhere classified |
| T14.0 | Superficial injury of unspecified body region (including abrasion, bruise, contusion, hematoma, bite of nonvenomous insect) |
| T30 | Burns and corrosions of unspecified body region |
| ICD-11 code | Indication |
| 9A06.70 | Atopic eczema of the eyelids |
| EA40 | Tropical phagedenic ulcer |
| EA80.0 | Infantile atopic eczema |
| EA80.1 | Childhood atopic eczema |
| EA80.2 | Adult atopic eczema |
| EA80.Z | Atopic eczema, unspecified |
| EA82 | Nummular dermatitis |
| EA85.20 | Atopic hand eczema |
| EA85.2Z | Hand dermatitis, unspecified |
| EA85.3 | Foot dermatitis |
| EA89 | Generalized eczematous dermatitis of unspecified type |
| EA8Z | Dermatitis or eczema, unspecified |
| EF60 | Ischemic ulceration of the skin |
| EH40.10 | Diaper dermatitis |
| EH90.Z | Pressure ulcer of unspecified degree |
| EH92 | Dermatoses provoked by friction or mechanical impact |
| EH92.1 | Blister due to friction |
| EK00.Z | Allergic contact dermatitis, unspecified |
| EK02.20 | Intertriginous dermatitis due to friction, sweating or contact with body fluids |
| EK02.Z | Irritant contact dermatitis, unspecified |
| EK5Y | Other specified skin lesions provoked by exposure to external factors |
| EM0Z | Unspecified skin disorder |
| ME60.2 | Ulcerative skin lesion of unspecified nature |
| ND56.0 | Superficial injury of unspecified body region |
| NE11 | Burn of unspecified body region |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply the preparation externally only. Ensure the skin is clean and dry before application.
For the prevention of diaper rash in infants and children, apply a thin layer to the buttocks, groin, genital area, and skin folds after each diaper change.
For the treatment of diaper dermatitis, miliaria, and intertrigo, apply a thin layer to the affected areas two to three times daily or with every diaper change.
For superficial wounds, burns, and ulcerative skin lesions, apply a thin layer to cover the affected area one to two times daily after cleansing.
For dermatitis and eczema, apply a thin layer to the irritated skin as needed to relieve weeping and inflammation.
Avoid inhalation of powder dust. Do not apply to extensively exuding or heavily bleeding wounds. Discontinue use and consult a physician if irritation occurs or if the condition worsens.
Adverse Reactions
Allergic reactions such as skin itching, hyperemia, skin rash are possible.
Contraindications
Hypersensitivity to zinc oxide.
Use in Pregnancy and Lactation
Can be used during pregnancy and breastfeeding if indicated, in the recommended doses.
Pediatric Use
Can be used in children if indicated, in the recommended doses and dosage forms.
Special Precautions
It is not recommended to use zinc oxide preparations in acute purulent-inflammatory diseases.
Avoid contact with the eyes.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Powder for topical application: jars or bottles 20 g, 30 g, 40 g or 50 g
Marketing Authorization Holder
Aromasintez, LLC (Russia)
Dosage Form
 |
Baby powder | Powder for topical application: jars or bottles 20 g, 30 g, 40 g or 50 g |
Dosage Form, Packaging, and Composition
Powder for topical application white or greyish-white, soft, greasy to the touch; when rubbed between the palms, no grains or lumps should be felt.
| 100 g | |
| Zinc oxide | 10 g |
Excipients: potato starch – 10 g, talc – 80 g.
20 g – jars (1) or bottles – cardboard packs.
30 g – jars (1) or bottles – cardboard packs.
40 g – jars (1) or bottles – cardboard packs.
50 g – jars (1) or bottles – cardboard packs.
Powder for topical application: sachets 2 g or 5 g 3, 5, 10, 20 or 30 pcs., jars 40 g or 50 g 1 pc.
Marketing Authorization Holder
Ivanovo Pharmaceutical Factory PJSC (Russia)
Dosage Form
|
Baby powder | Powder for topical application: sachets 2 g or 5 g 3, 5, 10, 20 or 30 pcs., jars 40 g or 50 g 1 pc. |
Dosage Form, Packaging, and Composition
Powder for topical application white or greyish-white in color, soft, greasy to the touch; when rubbed between the palms, no grains or lumps should be felt.
| 100 g | |
| Zinc oxide | 10 g |
Excipients: potato starch – 10 g, talc – 80 g.
2 g – heat-sealed sachets (3) – cardboard packs.
2 g – heat-sealed sachets (5) – cardboard packs.
2 g – heat-sealed sachets (10) – cardboard packs.
2 g – heat-sealed sachets (20) – cardboard packs.
2 g – heat-sealed sachets (30) – cardboard packs.
5 g – heat-sealed sachets (3) – cardboard packs.
5 g – heat-sealed sachets (5) – cardboard packs.
5 g – heat-sealed sachets (10) – cardboard packs.
5 g – heat-sealed sachets (20) – cardboard packs.
5 g – heat-sealed sachets (30) – cardboard packs.
40 g – polymer jars (1) – cardboard packs.
50 g – polymer jars (1) – cardboard packs.
Powder for topical application: jars 40 g or 50 g
Marketing Authorization Holder
Sintez PJSC (Russia)
Dosage Form
|
Baby powder | Powder for topical application: jars 40 g or 50 g |
Dosage Form, Packaging, and Composition
Powder for topical application white or greyish-white in color, soft, greasy to the touch; when rubbed between the palms, no grains or lumps should be felt.
| 100 g | |
| Zinc oxide | 10 g |
Excipients: potato starch, talc.
40 g – polyethylene jars.
50 g – polyethylene jars.
Powder for topical application 80 g+10 g+10 g/100 g: jar 50 g
Marketing Authorization Holder
Sintez PJSC (Russia)
Dosage Form
|
Baby powder | Powder for topical application 80 g+10 g+10 g/100 g: jar 50 g |
Dosage Form, Packaging, and Composition
Powder for topical application white or greyish-white in color, soft, greasy to the touch; when rubbed between the palms, no grains or lumps should be felt.
| 100 g | |
| Talc | 80 g |
| Zinc oxide | 10 g |
| Potato starch | 10 g |
40 g – polyethylene jars.
![Baby powder [Powder] 1](https://www.medixlife.com/wp-content/uploads/Medixlife_favi_512.png "Baby powder [Powder] 2")